Anticancer and antiproliferative activity of ruthenium complex (II) bearing 3,3’-dicarboxy-2,2’-bipyridine ligand
Even though significant progress has been made in cancer treatment, there is always room for improvement. The experimental drug Ruthenium Complex II shows promise as a cancer treatment. In this article, the dichloro-3,3’-dicarboxy-2,2’-bipyridyl bis(dimethylsulphoxide)ruthenium(II) [RuCl2(3,3’-dcbpy...
Main Author: | Mohamed Saadh |
---|---|
Format: | Article |
Language: | English |
Published: |
Pensoft Publishers
2023-09-01
|
Series: | Pharmacia |
Online Access: | https://pharmacia.pensoft.net/article/111508/download/pdf/ |
Similar Items
-
Synthesis, characterization and antibacterial activity of ruthenium complex bearing 3,3’-dicarboxy-2,2’-bipyridine ligand
by: Mohammed A. Al-Wahish, et al.
Published: (2023-06-01) -
Antiproliferative activity of ruthenium complex II against human cancer cell in vitro
by: Mohamed Saadh
Published: (2023-09-01) -
Anticancer Activity and Apoptosis Induction of Gold(III) Complexes Containing 2,2′-Bipyridine-3,3′-dicarboxylic Acid and Dithiocarbamates
by: Ali Alhoshani, et al.
Published: (2021-06-01) -
Highly Sensitive Detection of the Insecticide Azamethiphos by Tris(2,2′-bipyridine)ruthenium(II) Electrogenerated Chemiluminescence
by: Tesfaye Hailemariam Barkae, et al.
Published: (2022-03-01) -
Bis(2,2′-bipyridine)(pyridin-2-olato)ruthenium(II) hexafluoridophosphate benzene hemisolvate
by: Tomohiko Hamaguchi, et al.
Published: (2011-12-01)